Name of organisation
1) Department/Research groupGlobal Database Studies, GloDaSt
2) Organisation/affiliationIQVIA
Short Name in the inventoryIQVIA
Administrative Contact
Title Ms
Last name ENCePP IQVIA Coordinator
First name -
Address line 1StatFinn Oy
Address line 2Metsänneidonkuja 6
Address line 3
CityEspoo
Postcode02130
CountryFinland
Phone number (incl. country code)358-40-8643912
Alternative phone number
Fax number (incl. country code)
Scientific Contact
Title Dr
Last name Hoti
First name Fabian
Address line 1StatFinn Oy
Address line 2Metsänneidonkuja 6
Address line 3
CityEspoo
Postcode02130
CountryFinland
Phone number (incl. country code)358-40-5391919
Alternative phone number
Fax number (incl. country code)
2. Description
IQVIA is a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry dedicated to creating intelligent connections that deliver unique innovations and actionable insights. As part of IQVIA, Global Database Studies (GloDaSt) specialises in provision of Real World Evidence (RWE) studies and high quality pharmacoepidemiology research. We utilise Real World Data from various health registries with patient-level information on drug prescriptions, diagnoses, treatments and outcomes. Our offerings include feasibility studies, post-authorisation safety studies, drug utilisation studies and relative effectiveness studies. Our methodology combines clinical, pharmacological, epidemiological and statistical knowledge.
3. Category
For profit organisation
4. Available resources
In houseVia Contacts/Network
Epidemiologist/Pharmacoepidemiologist
Yes
No
Statistician
Yes
No
Clinician
Yes
No
Clinical Pharmacologist
Yes
No
Pharmacist
Yes
No
Geneticist/Pharmacogeneticist
Yes
No
IT specialist
Yes
No
Ethics expertise
Yes
No
Legal expertise
Yes
No
Regulatory expertise
Yes
No
Programmers
Yes
No
5. Therapeutic/disease areas of research in drug safety/risk-benefit performed in the past 5 years
Cardiovascular diseases
Congenital Malformations
Disorders of the central nervous system
Endocrine disorders
Gynaecology
Malignant disease
Osteoporosis
Pregnancy
Psychiatry
Respiratory diseases
Urinary tract disorders
6. Design of drug safety/risk-benefit studies published in the past 5 years
Cohort Study
Case Control Study
Drug Utilisation
Meta-Analysis
7. Experience in collecting data directly from individual patients/respondents
Number of Studies
Less than 5
Number of patients/respondents involved in the study(ies)
Between 1500 and 14999
8. Access to data collection resources
Capacity to conduct face-to-face interviews
No
Electronic data capture systems
Yes
System used:
National Health Care Registers
Interactive voice response systems
No
Call centre
No
9. Experience in secondary research and meta-analysis
Yes
10. Work with existing data resources in the past 3 years
Name of data resourceNo. of studies
Nordic Patient Registers30
Nordic Population Registers18
Nordic Prescription Registers34
Nordic Causes of Death Registers22
Nordic Cancer Registers12
11. Registries established by centre
None
12. Experience in collaboration in a study team
Principal Investigator
Collaborating Investigator
13. Current involvement in research networks
None